ISPC
iSpecimen Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$1.54
+0.00%Margins
Gross margin
-151.5%
EBITDA margin
-2198.0%
EBIT margin
-2020.0%
Net margin
-2449.0%
FCF margin
-1716.5%
-657.7%
Return on equity
-154.5%
Return on assets
-476.4%
Return on invested capital
0.07x
Asset turnover
-$7.0M
Cash from operations
$1.75
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026